"We want to understand how people cope with tinnitus”

Brain imaging

A Bluetooth headset and wireless microphone in one

Connect Clip

Read here your new AWN print special issue (free flipbook)

ENT World Congress Audiology Worldnews special

Get the latest news of the profession: sign up for our newsletter!

Audiology Worldnews newsletter

Market forecast for hearing implants: 2015-2025

Cochlear Implants Market Forecast

Interested in Audiology-related events?

Audiology Worldnews agenda

TINNET as the next step in tinnitus research: Towards evidence-based medicine

The Tinnitus Research Initiative (TRI) has come a long way to bring tinnitus research from several scientific fields together. The European funded TINNET, 'Better Understanding the Heterogeneity of Tinnitus to Improve and Develop New Treatments', can be regarded as the next step. It aims at coordination and standardization in tinnitus research and the enlargement of an already existing database with results from clinical trials. This should lead to a statistically relevant basis for tinnitus research. It promises the opportunity of standardized processes to enable tailor-made assessment for individual patients.

“At the start of the TRI in 2006 as a private initiative, there was only little tinnitus research compared to the number of people suffering from it. This research was isolated and results remained within the separated domains of ENT, audiology, psychology, psychiatry, and etcetera”, Dr. Berthold Langguth, head of the tinnitus center of Regensburg University concludes. TRI had the vision to bring disciplines together and to share results and insights. “Back then”, Langguth remembers, “the general assumption and conclusion were: 'Tinnitus cannot be cured, so learn to live with it'. The people involved in TRI, however, shared the belief that tinnitus should be treatable in principle – for instance with brain stimulation– although this treatment nor any other treatment was not proven yet. Their motto was and still is: 'Together for a cure'.” Since then, a lot has been achieved. For many patients, the suffering from tinnitus has been reduced.

Evidence base

“But tinnitus still is a very heterogeneous illness. It is difficult to treat”, says Langguth, “treatment is for a large part still mainly pioneering, the domain of pilot studies.” As yet, there are no clearly evidence based treatment methods except cognitive behavioral therapy (CBT) – which comes in several forms. Langguth: “But this doesn't affect the tinnitus percept itself, CBT has the goal to facilitate coping with it. While this provides important relief in many cases, it is not yet the solution for every patient suffering from tinnitus. Apart from that, there are many, many approaches with different rationales. Hearing loss compensation, optionally combined with forms of auditory stimulation, is widely accepted, but large controlled studies demonstrating the efficacy of these approaches are needed. Various innovative forms of individualized auditory stimulation offer sounds or music in frequency areas in the neighborhood of the tinnitus frequency. These forms of individualized auditory stimulation can interact with the neuronal mechanisms that generate tinnitus and have shown promising results in pilot studies.” But there is still a lot unclear, Langguth emphasizes: “How large are the clinical effects? Which variant works best with which type(s) of patients? What can we expect from pharmacological treatment or magnetic and electric brain stimulation? Before these newly developed treatments can be implemented in clinical routine, a conclusive statistical basis from large studies would be needed.”

New knowledge

The TINNET initiative was initiated to change this. It has now been approved by the European Cooperation in Science and Technology (COST) Committee of Senior Officials, thus ensuring European funding. “With that, we get the opportunity to lift tinnitus research to the next level. We still largely depend on the outcomes of isolated trials with a couple of dozens of heterogeneous patients, which causes results to partly depend on group configuration. When data from similar trials from dozens of centers or more can henceforth be introduced in the database, this opens a lot of opportunities.” Once detailed data from many persons is gathered, it will allow us to derive new knowledge, says Langguth: “We could understand in more detail what forms of tinnitus do exist and what the differences between the various forms are. The goal would be to create a data-based expert system, which would provide guidance of which treatment has the best chances for success in a given patient: So hopefully in some years, we can ask the database what would be the recommendation for a 56 years old male, who suffers from a tonal tinnitus since a noise trauma two years ago, and the database would tell us, that a combination of drug X and auditory stimulation Y is the most promising first-line treatment for this individual.”

Dr. Berthold Langguth held a speech on the TINNET initiative during the 8th TRI international Conference from 10-13 March in Auckland, New Zealand. COST invites tinnitus researchers from as many European countries as possible to participate in the project.

Leendert van der Ent

Photo: Lasse Designen - Fotolia
“The future could be so bright we will need to wear shades”
“The future could be so bright we will need to wear shades”


© liusishan - iStock

Geoffrey Cooling, regular contributor to Audio Infos United Kingdom, shares with us some insights on how technology could transform the industry. As usual, the expert invites us to welcome new challenges with a smile.

62nd EUHA Congress and its AWN congress special are here!
62nd EUHA Congress and its AWN congress special are here!

EUHA 2017

For the 62nd international gathering of hearing care professionals from 90 countries, we bring you the fourth edition of our Audiology Worldnews EUHA Congress Special Issue.

Interview to Martin Blecker, EUHA President
Interview to Martin Blecker, EUHA President

EUHA 2017

The 62nd EUHA congress will start this Wednesday, October 18th, in Nuremberg. According to EUHA president Martin Blecker the main issues of this year's congress are nothing less than the future of hearing aid acoustics!

UK Audiologists on a mission in Armenia
UK Audiologists on a mission in Armenia


Ian Croston and Jonathan Le Brun with a patient delighted to be hearing. © Starkey Hearing

Representatives of Starkey Hearing Technologies in the UK have taken a team of hearing care professionals on a hearing mission to Armenia.

Audiology delivers most cost-effective tinnitus therapies
Audiology delivers most cost-effective tinnitus therapies

© ands456- iStock


A study funded by the British Tinnitus Association (BTA) into the healthcare cost of tinnitus management in the UK has calculated that the average cost of tinnitus treatment per patient per year is £717, equating to an NHS healthcare bill of £750 million per year.

Universal newborn hearing screening not enough to improve language skills
Universal newborn hearing screening not enough to improve language skills

© aluxum - iStock


Universal newborn hearing screening (NHS) is not sufficient to improve language skills in children who are deaf or hard-of-hearing, according to a new study carried out by researchers at Cincinnati Children’s Hospital Medical Center, Ohio (USA).

Phonak Audéo B-Direct "Made for All": a new era of connectivity
Phonak Audéo B-Direct

International launch

Thomas Lang, Senior Vice President Product Marketing ©D.K.

Denmark, home of Bluetooth, was the specifically chosen venue for the unveiling of the Phonak Audéo B-Direct. Hundreds of audiologists at the conference centre were joined by many more on the live streaming of the launch of a product Phonak say is Made for All.

Company Directory

New products

Widex announces the completely redesigned WIDEX CUSTOM™Widex announces the completely redesigned WIDEX CUSTOM™

On October 17, Widex announces the new WIDEX CUSTOM™ - a completely redesigned in the ear hearing aid with a 40% smaller engine compared to previous models.  [ ... ]

Sonic showcases newest additions to Enchant family at EUHA 2017Sonic showcases newest additions to Enchant family at EUHA 2017

Sonic will showcase the new rechargeable Enchant miniRITE with ZPower and versatile SoundClip-A at the annual EUHA congress in Nuremberg, Germany.  [ ... ]

power one: complete range of hearing aid batteries on show at EUHA 2017power one: complete range of hearing aid batteries on show at EUHA 2017

Every individual is unique, and hearing aid requirements are equally diverse. Factors such as lifestyle, leisure activities and age must all be taken into account to ensure everybody has the right energy solution for their device.  [ ... ]